Large-scale testing (Phase 3)Ended earlyNCT03810313
What this trial is testing
Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
Who this might be right for
Central Retinal Vein Occlusion
Novartis Pharmaceuticals 493